...

Adopt a collaborative
Molecular Tumour Board

Molecular Tumour Board teams use Vitae Evidence's precision medicine software solution to find personalised, actionable treatment options tailored to each patient’s molecular profile and personal preferences.

Harmonise all stakeholders' competence by optimising essential processes in a patient-oriented manner and according to the latest best practices.

Build collaborative, cross-border expertise, by incorporating expert knowledge from all user sites while respecting data privacy, attribution and confidentiality.

Automate evidence generation and its integration with clinical information in a fully transparent and controllable process.

Establish a continuously learning healthcare system, by incorporating experience from previous cases and outcomes, automatically analyzing newly published evidence, and integrating with the existing infrastructure.

How it works

Vitae Evidence is a ce-marked, cloud-based Medical Device software. It uses Explainable Artificial Intelligence (XAI) to extract relevant evidence to assist clinicians and reassure patients that all options have been considered, including available and recruiting clinical trials.

1) Post your Case Description

Enter the age, sex, cancer type and stage, performance status, already tested biomarkers, current and past treatment. Indicate any lifestyle, profession, or patient preferences that may impact choice of treatment.


Or connect your electronic health records and other clinical data repositories to generate cases automatically and at scale.

2) Find Evidence, assisted by AI

Vitae Evidence algorithms summarize evidence from practice guidelines, EMA/FDA/NoMA, ASCO/ESMO news, PubMed and medRxiv, trial registries, biomedical databases, and past cases. The tool suggests actionable biomarkers, treatments and recruiting clinical trials, ranked according to the case relevance and evidence quality.


Automate evidence generation and its integration with clinical information in a fully transparent and controllable process.

3) Review the report

Work together with other analysts and clinicians on a case report. Your quality controlled contributions may be reused for future similar cases. Permissions to access the case data can be set at the user or group level, and others will only view aggregated data.


Build collaborative, cross-border expertise, by incorporating expert knowledge from all user sites while respecting data privacy, attribution and confidentiality.

4) Share the decision-making

After the Molecular Tumour Board's presentation, the Case Manager sends the eReport to the treating physician, the patient and his next-of-kin, who will then have everything they need to take a fully informed, evidence-based, all options considered, shared decision.


Harmonize all stakeholder's competence, by optimising essential processes in a patient-oriented manner and according to the latest best practices. The graphical user interface is tailored to the user's role.

Digital Health

Are you looking for a case team?

Are you looking for a team to help manage a complex case or to walk you through your first case?

Or do you want to improve patient participation, tap into precision medicine expertise and a pool of case coordinators?

Learn about Coremine Vitae
Security & Quality

Our regulatory processes for Software as Medical Devices

GDPR Compliant

Registered CE-Mark at NoMA (MDD Class I)

We apply ISO 13485 Quality Management System

We leverage ISO/IEC 27001 certified hosted solutions

Get Started

Start delivering personalised medicine insights at scale. Collaborative learning powered by AI.

Get early access